X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

ASMB

Closed

Assembly Biosciences Inc

17.73
-0.39 (-2.15%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 18.12
Day's Range: 17.45 - 18.9153
Send
When Written:
 
0.8404
Assembly Biosciences Inc is a clinical-stage biotechnology company that is focused on developing innovative therapies for the treatment of hepatitis B virus (HBV) and other viral diseases. The company is headquartered in South San Francisco, California, and was founded in 2005.

Assembly Biosciences is developing a pipeline of novel oral therapeutics that aim to improve the cure rates for chronic HBV infection. The company's lead product candidate, ABI-H0731, is a potent and selective HBV core inhibitor that has shown promising results in early-stage clinical trials.

In addition to its HBV program, Assembly Biosciences is also developing a pipeline of therapies for the treatment of other viral diseases, including human papillomavirus (HPV) and norovirus.

Assembly Biosciences has partnerships with several leading pharmaceutical companies, including Allergan, Janssen Pharmaceuticals, and Roche. The company is also backed by several prominent investors, including Venrock, New Enterprise Associates, and Frazier Healthcare Partners.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X